Your browser doesn't support javascript.
loading
Triple-negative breast cancer in Peru: 2000 patients and 15 years of experience.
De-la-Cruz-Ku, Gabriel; Luyo, Marianne; Morante, Zaida; Enriquez, Daniel; Möller, Mecker G; Chambergo-Michilot, Diego; Flores, Lucero; Luque, Renato; Saavedra, Antonella; Eyzaguirre-Sandoval, Miguel E; Luján-Peche, María G; Noel, Naysha; Calderon, Hafid; Razuri, Cesar; Fuentes, Hugo A; Cotrina, Jose Manuel; Neciosup, Silvia P; Araujo, Jhajaira; Lema, Alexandra; Pinto, Joseph; Gomez, Henry L; Valcarcel, Bryan.
Afiliação
  • De-la-Cruz-Ku G; School of Medicine, Universidad Científica del Sur (UCSUR), Lima, Peru.
  • Luyo M; Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Morante Z; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru.
  • Enriquez D; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru.
  • Möller MG; Division of Surgical Oncology, University of Miami Miller School of Medicine, Jackson Memorial Hospital/Sylvester Comprehensive Cancer Center, Miami, FL, United States of America.
  • Chambergo-Michilot D; School of Medicine, Universidad Científica del Sur (UCSUR), Lima, Peru.
  • Flores L; Tau-RELAPED Group, Trujillo, Peru.
  • Luque R; School of Medicine, Universidad Científica del Sur (UCSUR), Lima, Peru.
  • Saavedra A; School of Medicine, Universidad Científica del Sur (UCSUR), Lima, Peru.
  • Eyzaguirre-Sandoval ME; Sociedad Científica de Estudiantes de Medicina Humana (SCIEM UCSUR), Lima, Peru.
  • Luján-Peche MG; School of Medicine, Universidad Científica del Sur (UCSUR), Lima, Peru.
  • Noel N; Sociedad Científica de Estudiantes de Medicina Humana (SCIEM UCSUR), Lima, Peru.
  • Calderon H; School of Medicine, Universidad Científica del Sur (UCSUR), Lima, Peru.
  • Razuri C; Sociedad Científica de Estudiantes de Medicina Humana (SCIEM UCSUR), Lima, Peru.
  • Fuentes HA; School of Medicine, Universidad Científica del Sur (UCSUR), Lima, Peru.
  • Cotrina JM; Sociedad Científica de Estudiantes de Medicina Humana (SCIEM UCSUR), Lima, Peru.
  • Neciosup SP; School of Medicine, Universidad Científica del Sur (UCSUR), Lima, Peru.
  • Araujo J; School of Medicine, Universidad Científica del Sur (UCSUR), Lima, Peru.
  • Lema A; Sociedad Científica de Estudiantes de Medicina Humana (SCIEM UCSUR), Lima, Peru.
  • Pinto J; Hospital Nacional Dos de Mayo, Lima, Peru.
  • Gomez HL; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru.
  • Valcarcel B; Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru.
PLoS One ; 15(8): e0237811, 2020.
Article em En | MEDLINE | ID: mdl-32833983
BACKGROUND: Epidemiological studies commonly identify the clinical characteristics and survival outcomes of patients with breast cancer at five years. Our study aims to describe the sociodemographic, clinicopathological characteristics and determine the long-term event-free survival (EFS) and overall survival (OS) of a Peruvian population with triple-negative breast cancer. METHODS: We reviewed the medical records of new cases treated at a single institution in the period 2000-2014. The survival analysis included patients with stages I-IV. Survival estimates at 10 years were calculated with the Kaplan-Meier method and compared with the Log-rank test. We further used multivariate Cox regression analysis to calculate prognostic factors of recurrence and mortality. RESULTS: Among the 2007 patients included, the median age at diagnosis was 49 years (19-95 years). Most patients presented histologic grade III (68.7%), tumor stage II (34.2%), and III (51.0%) at diagnosis. Local and distant relapse was present in 31.9 and 51.4% of the patients, respectively. The most frequent sites of metastasis were the lungs (14.5%), followed by bone (9.7%), brain (9.6%), and liver (7.9%). The median follow-up was 153 months. At 3, 5, and 10 years, the EFS of the population was 55%, 49%, and 41%, respectively, while the OS was 64%, 56%, and 47%, respectively. Moreover, an N3 lymph node status was the most important prognostic factor for both disease relapse (HR: 2.54, 95% CI: 2.05-3.15) and mortality (HR: 2.51, 95% CI: 2.01-3.14) at ten years. An older age and higher T staging were associated with a worse OS, while patients who received radiotherapy and adjuvant chemotherapy had better survival rates. CONCLUSION: The sociodemographic features of Peruvian patients with TNBC are similar to those of other populations. However, our population was diagnosed at more advanced clinical stages, and thus, EFS and OS were lower than international reports while prognostic factors were similar to previous studies.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: America do sul / Peru Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Peru

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: America do sul / Peru Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Peru